28 related articles for article (PubMed ID: 9793264)
21. The soluble interleukin-2 receptor as a new biological marker in diseases.
Pizzolo G
Allergol Immunopathol (Madr); 1991; 19(4):176-80. PubMed ID: 1818519
[No Abstract] [Full Text] [Related]
22. Tumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non-Hodgkin's lymphoma.
Pérez-Encinas M; Villamayor M; Campos A; González S; Bello JL
Haematologica; 1998 Aug; 83(8):752-4. PubMed ID: 9793264
[TBL] [Abstract][Full Text] [Related]
23. [Tumor markers in malignant lymphoma].
Kato H; Ogura M
Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
[TBL] [Abstract][Full Text] [Related]
24. Soluble molecules in lymphoproliferative disorders.
Vinante F; Morosato L; De Sabata D; Pizzolo G
Leukemia; 1991; 5 Suppl 1():18-21. PubMed ID: 1653881
[No Abstract] [Full Text] [Related]
25. [Clinical significance of biological prognostic factors in non-Hodgkin lymphoma: analysis of serum and cell surface nm 23-H1 protein].
Niitsu N
Rinsho Ketsueki; 2003 Apr; 44(4):211-8. PubMed ID: 12784653
[No Abstract] [Full Text] [Related]
26. [Pathologic anatomy and immunohistology of non-Hodgkin's lymphoma].
Feller AC
Internist (Berl); 1993 Feb; 34(2):106-13. PubMed ID: 8454422
[No Abstract] [Full Text] [Related]
27. Serum CD44 in non-Hodgkin's lymphoma.
Ristamäki R; Joensuu H; Jalkanen S
Leuk Lymphoma; 1999 May; 33(5-6):433-40. PubMed ID: 10342571
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
